A detailed history of Tocqueville Asset Management L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 737,381 shares of MRK stock, worth $83.7 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
737,381
Previous 788,836 6.52%
Holding current value
$83.7 Million
Previous $104 Million 12.3%
% of portfolio
1.52%
Previous 1.72%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $6.37 Million - $6.84 Million
-51,455 Reduced 6.52%
737,381 $91.3 Million
Q1 2024

May 09, 2024

SELL
$113.24 - $131.95 $317,185 - $369,591
-2,801 Reduced 0.35%
788,836 $104 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $320,375 - $348,645
3,198 Added 0.41%
791,637 $86.3 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $1.96 Million - $2.18 Million
-19,044 Reduced 2.36%
788,439 $81.2 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $7,711 - $8,404
-71 Reduced 0.01%
807,483 $93.2 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $6.16 Million - $6.87 Million
-59,808 Reduced 6.9%
807,554 $85.9 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $709,313 - $909,436
-8,112 Reduced 0.93%
867,362 $96.2 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $107,268 - $120,504
-1,269 Reduced 0.14%
875,474 $75.4 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $1.27 Million - $1.44 Million
-15,210 Reduced 1.71%
876,743 $79.9 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $783,102 - $877,807
-10,653 Reduced 1.18%
891,953 $73.2 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $1.64 Million - $2.05 Million
-22,635 Reduced 2.45%
902,606 $69.2 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $799,375 - $879,112
-11,152 Reduced 1.19%
925,241 $69.5 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $2.75 Million - $3.04 Million
-39,147 Reduced 4.01%
936,393 $72.8 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $3.83 Million - $4.51 Million
55,581 Added 6.04%
975,540 $75.2 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $3.84 Million - $4.26 Million
53,545 Added 6.18%
919,959 $75.3 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $1.09 Million - $1.24 Million
-14,891 Reduced 1.69%
866,414 $71.9 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $7.81 Million - $8.89 Million
110,954 Added 14.4%
881,305 $68.2 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.26 Million - $1.75 Million
-19,945 Reduced 2.52%
770,351 $59.3 Million
Q4 2019

Jan 14, 2020

SELL
$77.58 - $87.54 $16.8 Million - $18.9 Million
-216,301 Reduced 21.49%
790,296 $71.9 Million
Q3 2019

Oct 31, 2019

SELL
$76.08 - $82.93 $1.29 Million - $1.41 Million
-16,996 Reduced 1.66%
1,006,597 $84.7 Million
Q2 2019

Jul 31, 2019

SELL
$69.84 - $81.59 $137,934 - $161,140
-1,975 Reduced 0.19%
1,023,593 $85.8 Million
Q1 2019

Apr 30, 2019

SELL
$69.58 - $79.36 $7.26 Million - $8.28 Million
-104,335 Reduced 9.23%
1,025,568 $85.3 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $13.2 Million - $15.3 Million
-202,271 Reduced 15.18%
1,129,903 $86.3 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $2.08 Million - $2.44 Million
-35,972 Reduced 2.63%
1,332,174 $94.5 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $1.6 Million - $1.88 Million
-31,505 Reduced 2.25%
1,368,146 $83 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $1.29 Million - $1.5 Million
25,404 Added 1.85%
1,399,651 $76.2 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $17.6 Million - $21 Million
340,151 Added 32.89%
1,374,247 $77.3 Million
Q3 2017

Oct 30, 2017

BUY
$58.67 - $63.13 $60.7 Million - $65.3 Million
1,034,096
1,034,096 $66.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.